These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 10418958)

  • 21. Comparison of the hepatotoxicity of coumarin in the rat, mouse, and Syrian hamster: a dose and time response study.
    Lake BG; Grasso P
    Fundam Appl Toxicol; 1996 Nov; 34(1):105-17. PubMed ID: 8937898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the disposition, metabolism and hepatotoxicity of coumarin in the rat and Syrian hamster.
    Lake BG; Evans JG; Chapuis F; Walters DG; Price RJ
    Food Chem Toxicol; 2002 Jun; 40(6):809-23. PubMed ID: 11983276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Species differences in the metabolism and hepatotoxicity of coumarin.
    Fentem JH; Fry JR
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Jan; 104(1):1-8. PubMed ID: 8097443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The FEMA GRAS assessment of trans-anethole used as a flavouring substance. Flavour and Extract Manufacturer's Association.
    Newberne P; Smith RL; Doull J; Goodman JI; Munro IC; Portoghese PS; Wagner BM; Weil CS; Woods LA; Adams TB; Lucas CD; Ford RA
    Food Chem Toxicol; 1999 Jul; 37(7):789-811. PubMed ID: 10496381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Final report on the safety assessment of Trichloroethane.
    Int J Toxicol; 2008; 27 Suppl 4():107-38. PubMed ID: 19101834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Toxicological research and safety consideration of coumarins].
    Guo PJ; Lin ZJ; Zhang XM; Zou LN; Guo FF; Zhang B
    Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):518-522. PubMed ID: 32237508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Final report on the safety assessment of Triethylene Glycol and PEG-4.
    Int J Toxicol; 2006; 25 Suppl 2():121-38. PubMed ID: 17090481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of carcinogenicity studies of medicinal products for human use authorised via the European centralised procedure (1995-2009).
    Friedrich A; Olejniczak K
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):225-48. PubMed ID: 21513764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the potential carcinogenicity and genetic toxicity to humans of the herbicide acetochlor.
    Ashby J; Kier L; Wilson AG; Green T; Lefevre PA; Tinwell H; Willis GA; Heydens WF; Clapp MJ
    Hum Exp Toxicol; 1996 Sep; 15(9):702-35. PubMed ID: 8880207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of tolerance to Clara cell necrosis with repeat administration of coumarin.
    Born SL; Fix AS; Caudill D; Lehman-McKeeman LD
    Toxicol Sci; 1999 Oct; 51(2):300-9. PubMed ID: 10543032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic detoxification determines species differences in coumarin-induced hepatotoxicity.
    Vassallo JD; Hicks SM; Daston GP; Lehman-McKeeman LD
    Toxicol Sci; 2004 Aug; 80(2):249-57. PubMed ID: 15141102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of coumarin and 7-ethoxycoumarin by rat, mouse, guinea pig, cynomolgus monkey and human precision-cut liver slices.
    Steensma A; Beamand JA; Walters DG; Price RJ; Lake BG
    Xenobiotica; 1994 Sep; 24(9):893-907. PubMed ID: 7810171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Species-specific differences in coumarin-induced hepatotoxicity as an example toxicogenomics-based approach to assessing risk of toxicity to humans.
    Uehara T; Kiyosawa N; Shimizu T; Omura K; Hirode M; Imazawa T; Mizukawa Y; Ono A; Miyagishima T; Nagao T; Urushidani T
    Hum Exp Toxicol; 2008 Jan; 27(1):23-35. PubMed ID: 18480146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-mutagenicity of coumarin (1,2-benzopyrone) with aflatoxin B1 and human liver S9 in mammalian cells.
    Goeger DE; Hsie AW; Anderson KE
    Food Chem Toxicol; 1999 Jun; 37(6):581-9. PubMed ID: 10478826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective Clara cell injury in mouse lung following acute administration of coumarin.
    Born SL; Fix AS; Caudill D; Lehman-McKeeman LD
    Toxicol Appl Pharmacol; 1998 Jul; 151(1):45-56. PubMed ID: 9705886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in vitro skin absorption and metabolism of coumarin (1,2-benzopyrone) in human, rat, and mouse.
    Beckley-Kartey SA; Hotchkiss SA; Capel M
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):34-42. PubMed ID: 9221821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Final report on the safety assessment of methoxyisopropanol and methoxyisopropyl acetate as used in cosmetics.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 2():25-39. PubMed ID: 18830862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous absorption and metabolism of Coumarin in human and rat skin.
    Yourick JJ; Bronaugh RL
    J Appl Toxicol; 1997; 17(3):153-8. PubMed ID: 9250536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Next-Generation Risk Assessment Case Study for Coumarin in Cosmetic Products.
    Baltazar MT; Cable S; Carmichael PL; Cubberley R; Cull T; Delagrange M; Dent MP; Hatherell S; Houghton J; Kukic P; Li H; Lee MY; Malcomber S; Middleton AM; Moxon TE; Nathanail AV; Nicol B; Pendlington R; Reynolds G; Reynolds J; White A; Westmoreland C
    Toxicol Sci; 2020 Jul; 176(1):236-252. PubMed ID: 32275751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.